Page 16 of 19 – SEC Filing EXHIBIT A JOINT FILING AGREEMENT In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of BioCryst Pharmaceuticals, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts. In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 28th day of March, 2016. Venrock Healthcare Capital Partners, L.P. By: VHCP Management, LLC Its: General Partner By: /s/ David L. Stepp David L. Stepp Authorized Signatory VHCP Co-Investment Holdings, LLC By: VHCP Management, LLC Its: Manager By: /s/ David L. Stepp David L. Stepp Authorized Signatory VHCP Management, LLC By: /s/ David L. Stepp David L. Stepp Authorized Signatory Venrock Healthcare Capital Partners II, L.P. By: VHCP Management II, LLC Its: General Partner By: /s/ David L. Stepp David L. Stepp Authorized Signatory VHCP Co-Investment Holdings II, LLC By: VHCP Management II, LLC Its: Manager By: /s/ David L. Stepp David L. Stepp Authorized Signatory
VHCP Management II, LLC By: /s/ David L. Stepp David L. Stepp Authorized Signatory
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
EXHIBIT A
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them of a statement on Schedule 13G (including amendments thereto) with respect to the Common Stock of BioCryst Pharmaceuticals, Inc. and further agree that this agreement be included as an exhibit to such filing. Each party to the agreement expressly authorizes each other party to file on its behalf any and all amendments to such statement. Each party to this agreement agrees that this joint filing agreement may be signed in counterparts.
In evidence whereof, the undersigned have caused this Agreement to be executed on their behalf this 28th day of March, 2016.
| Venrock Healthcare Capital Partners, L.P. | ||
| By: VHCP Management, LLC | ||
| Its: General Partner | ||
| By: | /s/ David L. Stepp | |
| David L. Stepp | ||
| Authorized Signatory | ||
| VHCP Co-Investment Holdings, LLC | ||
| By: VHCP Management, LLC | ||
| Its: Manager | ||
| By: | /s/ David L. Stepp | |
| David L. Stepp | ||
| Authorized Signatory | ||
| VHCP Management, LLC | ||
| By: | /s/ David L. Stepp | |
| David L. Stepp | ||
| Authorized Signatory | ||
| Venrock Healthcare Capital Partners II, L.P. | ||
| By: VHCP Management II, LLC | ||
| Its: General Partner | ||
| By: | /s/ David L. Stepp | |
| David L. Stepp | ||
| Authorized Signatory | ||
| VHCP Co-Investment Holdings II, LLC | ||
| By: VHCP Management II, LLC | ||
| Its: Manager | ||
| By: | /s/ David L. Stepp | |
| David L. Stepp | ||
| Authorized Signatory | ||
| VHCP Management II, LLC | ||
| By: | /s/ David L. Stepp | |
| David L. Stepp | ||
| Authorized Signatory | ||
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
Follow Biocryst Pharmaceuticals Inc (NASDAQ:BCRX)
We may use your email to send marketing emails about our services. Click here to read our privacy policy.
